Ultrasound therapy for inflammation in ulcerative colitis
Part of Digestive system clinical trials.
This trial tests if low-intensity ultrasound waves applied to the colon can reduce inflammation in people with active ulcerative colitis. If successful, it could offer a new drug-free way to manage flare-ups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older with a confirmed diagnosis of ulcerative colitis.
- Your disease is moderate to severe and your doctor plans to start a new treatment (like a biologic or small molecule drug).
- You have a body mass index (BMI) below 23.
- You are not pregnant, breastfeeding, or using an implanted contraceptive device.
- You have no active infections, bleeding disorders, or metal implants that could interfere with the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a gentle ultrasound scan (on the outside of the body) to see how well treatment is working during a moderate to severe flare of ulcerative colitis. It aims to find out if this painless test can predict recovery and help guide care without needing a telescope exam (endoscopy).
This trial tests an experimental drug (ISM5411) for people with active ulcerative colitis. The goal is to see if the drug can reduce inflammation and improve symptoms.
This study tests a new medication called BI 3032950 for people with ulcerative colitis who have already tried other advanced treatments (biologics or targeted therapies) that didn't work well enough or caused problems. The goal is to see if the new drug is safe and helps control inflammation in the colon.
This trial tests a new treatment for people with ulcerative colitis (UC) whose disease is active despite taking only mesalamine or sulfasalazine. It aims to find a therapy that can reduce inflammation and improve symptoms.
This study checks biomarkers (signals in blood and/or stool) in adults with moderate-to-severe ulcerative colitis. It compares patients starting targeted medicines and looks for marker patterns that may reflect how the disease is behaving.
This trial tests whether a tailored anti-inflammatory diet based on American foods can help people with mild to moderately active ulcerative colitis. You'll follow a special meal plan with foods like soup, smoothies, salmon, and avocado, and researchers will track your symptoms and inflammation.
Hear when a new Ulcerative Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.